Grisnilimab
Product Specifications
CAS Number
2367001-70-3
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Purity
0.9963
Bioactivity
Grisnilimab (WT1) is a monoclonal antibody targeting CD7. CD7 plays a crucial role in T cell and T cell/B cell interactions, and the Wilms' tumour 1 (WT1) gene is overexpressed in leukaemia and various types of solid tumours (such as lung cancer and colorectal cancer) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1195475-01 0.02 mg (E-Coli)
Recombinant Aspidelaps scutatus Cytotoxin homolog S4C8
Sign In for Pricing
View Details MBS1195475-02 0.1 mg (E-Coli)
Recombinant Aspidelaps scutatus Cytotoxin homolog S4C8
Sign In for Pricing
View Details MBS1195475-03 0.02 mg (Yeast)
Recombinant Aspidelaps scutatus Cytotoxin homolog S4C8
Sign In for Pricing
View Details MBS1195475-04 0.1 mg (Yeast)
Recombinant Aspidelaps scutatus Cytotoxin homolog S4C8
Sign In for Pricing
View Details MBS1195475-05 0.02 mg (Baculovirus)
Recombinant Aspidelaps scutatus Cytotoxin homolog S4C8
Sign In for Pricing
View Details MBS1195475-06 1 mg (E-Coli)
Recombinant Aspidelaps scutatus Cytotoxin homolog S4C8
Sign In for Pricing
View Details